The Epoch Times
The Epoch Times
Focus

Caelum

Companies
Companies
|
Reuters

AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal

Sep 29, 2021
|
Reuters
FacebookXTruthGettrLinkedInTelegramEmail
AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal
Sep 29
|
FacebookXTruthGettrLinkedInTelegramEmail
Companies
Companies
|
Reuters

AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal

Sep 29, 2021
|
Reuters
FacebookXTruthGettrLinkedInTelegramEmail
AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal
Sep 29
|
FacebookXTruthGettrLinkedInTelegramEmail
home-iconepochtv-iconhealth-iconbright-iconepochfun-icon
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.